The global In Vivo Imaging Systems market size is predicted to grow from US$ 138 million in 2025 to US$ 167 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.

Small animal in vivo imaging technology is a non-invasive method widely used in biomedical research, which can observe and track biological processes in small animals in real time. Through this technology, researchers can gain a deep understanding of dynamic changes such as disease progression, drug response and gene expression. Common in vivo imaging technologies include optical imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), etc. This technology helps to reduce the use of experimental animals, provide more efficient and accurate experimental data, and promote the development of new drugs and the study of disease mechanisms. The main manufacturers of small animal in vivo imaging systems (In Vivo Imaging Systems) in the world include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories and Hallmarq Veterinary Imaging, etc. The top five manufacturers account for about 47% of the global market share. In terms of revenue, North America is the largest market, accounting for about 64% of the market share. In terms of product type, optical imaging is the largest segment, accounting for about 65% of the revenue share, and in terms of downstream, laboratories are the largest downstream field, accounting for 78% of the revenue share. In the small animal in vivo imaging industry, manufacturers need to take multiple measures to promote technological innovation and enhance market competitiveness. First, manufacturers should focus on technology research and development, and continuously improve the resolution, sensitivity and multimodal functions of imaging equipment so that they can more accurately capture biological processes in small animals. In addition, manufacturers should focus on developing user-friendly software platforms to ensure the automation and simplicity of data acquisition and analysis to reduce the operational burden of researchers and improve experimental efficiency. Secondly, manufacturers should strengthen cooperation with scientific research institutions and pharmaceutical companies to meet the needs of different industries and fields through customized solutions. For example, in cutting-edge fields such as cancer research, new drug development and gene therapy, providing targeted imaging equipment and services can effectively expand the market. At the same time, manufacturers should also pay attention to the cost-effectiveness of equipment, while maintaining high-quality imaging performance, by optimizing production processes and supply chains, reducing the manufacturing cost of equipment, making in vivo imaging technology more economically feasible, and attracting more small and medium-sized laboratories to use it. In addition, with the increasing global attention to animal welfare, manufacturers also need to ensure that their equipment complies with ethical standards and regulations, reduce unnecessary harm to experimental animals, and provide more accurate non-invasive imaging technology to help researchers achieve more humane experimental design. Finally, manufacturers should establish a comprehensive after-sales service system to provide equipment maintenance, technical support and operation training to ensure that users can use the equipment in a long-term and stable manner. Through a comprehensive layout in technology, cooperation, cost, ethics and service, manufacturers can maintain a sustained competitive advantage in the small animal in vivo imaging industry, meet the growing needs of scientific researchers and pharmaceutical companies, and promote the advancement of biomedical research.

LP Information, Inc. (LPI) ' newest research report, the “In Vivo Imaging Systems Industry Forecast” looks at past sales and reviews total world In Vivo Imaging Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vivo Imaging Systems sales for 2025 through 2031. With In Vivo Imaging Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vivo Imaging Systems industry.

This Insight Report provides a comprehensive analysis of the global In Vivo Imaging Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In Vivo Imaging Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vivo Imaging Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vivo Imaging Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vivo Imaging Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vivo Imaging Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Optical Imaging

    MRI

    Ultrasound

    Others

Segmentation by Application:

    Laboratory

    Pet Hospital and Clinic

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Perkin Elmer

    Canon Medical Systems

    Bruker

    Idexx Laboratories

    Hallmarq Veterinary Imaging

    Huantong Nuclear Magnet

    Sunny Optical

    Photon

    MILABS

    iThera Medical

    Vieworks

    Aspect Imaging

    TOMOWAVE

    Trifoil Imaging

    Clinx

    Raylight

    Spectral Instruments Imaging

    Novel Medical

    Tanon

    Biolight

    PINGSENG Healthcare

    Fujifilm Visualsonics

Key Questions Addressed in this Report

What is the 10-year outlook for the global In Vivo Imaging Systems market?

What factors are driving In Vivo Imaging Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do In Vivo Imaging Systems market opportunities vary by end market size?

How does In Vivo Imaging Systems break out by Type, by Application?

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global In Vivo Imaging Systems Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for In Vivo Imaging Systems by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for In Vivo Imaging Systems by Country/Region, 2020, 2024 & 2031
    2.2 In Vivo Imaging Systems Segment by Type
        2.2.1 Optical Imaging
        2.2.2 MRI
        2.2.3 Ultrasound
        2.2.4 Others
    2.3 In Vivo Imaging Systems Sales by Type
        2.3.1 Global In Vivo Imaging Systems Sales Market Share by Type (2020-2025)
        2.3.2 Global In Vivo Imaging Systems Revenue and Market Share by Type (2020-2025)
        2.3.3 Global In Vivo Imaging Systems Sale Price by Type (2020-2025)
    2.4 In Vivo Imaging Systems Segment by Application
        2.4.1 Laboratory
        2.4.2 Pet Hospital and Clinic
    2.5 In Vivo Imaging Systems Sales by Application
        2.5.1 Global In Vivo Imaging Systems Sale Market Share by Application (2020-2025)
        2.5.2 Global In Vivo Imaging Systems Revenue and Market Share by Application (2020-2025)
        2.5.3 Global In Vivo Imaging Systems Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global In Vivo Imaging Systems Breakdown Data by Company
        3.1.1 Global In Vivo Imaging Systems Annual Sales by Company (2020-2025)
        3.1.2 Global In Vivo Imaging Systems Sales Market Share by Company (2020-2025)
    3.2 Global In Vivo Imaging Systems Annual Revenue by Company (2020-2025)
        3.2.1 Global In Vivo Imaging Systems Revenue by Company (2020-2025)
        3.2.2 Global In Vivo Imaging Systems Revenue Market Share by Company (2020-2025)
    3.3 Global In Vivo Imaging Systems Sale Price by Company
    3.4 Key Manufacturers In Vivo Imaging Systems Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers In Vivo Imaging Systems Product Location Distribution
        3.4.2 Players In Vivo Imaging Systems Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for In Vivo Imaging Systems by Geographic Region
    4.1 World Historic In Vivo Imaging Systems Market Size by Geographic Region (2020-2025)
        4.1.1 Global In Vivo Imaging Systems Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global In Vivo Imaging Systems Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic In Vivo Imaging Systems Market Size by Country/Region (2020-2025)
        4.2.1 Global In Vivo Imaging Systems Annual Sales by Country/Region (2020-2025)
        4.2.2 Global In Vivo Imaging Systems Annual Revenue by Country/Region (2020-2025)
    4.3 Americas In Vivo Imaging Systems Sales Growth
    4.4 APAC In Vivo Imaging Systems Sales Growth
    4.5 Europe In Vivo Imaging Systems Sales Growth
    4.6 Middle East & Africa In Vivo Imaging Systems Sales Growth

5 Americas
    5.1 Americas In Vivo Imaging Systems Sales by Country
        5.1.1 Americas In Vivo Imaging Systems Sales by Country (2020-2025)
        5.1.2 Americas In Vivo Imaging Systems Revenue by Country (2020-2025)
    5.2 Americas In Vivo Imaging Systems Sales by Type (2020-2025)
    5.3 Americas In Vivo Imaging Systems Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC In Vivo Imaging Systems Sales by Region
        6.1.1 APAC In Vivo Imaging Systems Sales by Region (2020-2025)
        6.1.2 APAC In Vivo Imaging Systems Revenue by Region (2020-2025)
    6.2 APAC In Vivo Imaging Systems Sales by Type (2020-2025)
    6.3 APAC In Vivo Imaging Systems Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe In Vivo Imaging Systems by Country
        7.1.1 Europe In Vivo Imaging Systems Sales by Country (2020-2025)
        7.1.2 Europe In Vivo Imaging Systems Revenue by Country (2020-2025)
    7.2 Europe In Vivo Imaging Systems Sales by Type (2020-2025)
    7.3 Europe In Vivo Imaging Systems Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa In Vivo Imaging Systems by Country
        8.1.1 Middle East & Africa In Vivo Imaging Systems Sales by Country (2020-2025)
        8.1.2 Middle East & Africa In Vivo Imaging Systems Revenue by Country (2020-2025)
    8.2 Middle East & Africa In Vivo Imaging Systems Sales by Type (2020-2025)
    8.3 Middle East & Africa In Vivo Imaging Systems Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of In Vivo Imaging Systems
    10.3 Manufacturing Process Analysis of In Vivo Imaging Systems
    10.4 Industry Chain Structure of In Vivo Imaging Systems

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 In Vivo Imaging Systems Distributors
    11.3 In Vivo Imaging Systems Customer

12 World Forecast Review for In Vivo Imaging Systems by Geographic Region
    12.1 Global In Vivo Imaging Systems Market Size Forecast by Region
        12.1.1 Global In Vivo Imaging Systems Forecast by Region (2026-2031)
        12.1.2 Global In Vivo Imaging Systems Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global In Vivo Imaging Systems Forecast by Type (2026-2031)
    12.7 Global In Vivo Imaging Systems Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Perkin Elmer
        13.1.1 Perkin Elmer Company Information
        13.1.2 Perkin Elmer In Vivo Imaging Systems Product Portfolios and Specifications
        13.1.3 Perkin Elmer In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Perkin Elmer Main Business Overview
        13.1.5 Perkin Elmer Latest Developments
    13.2 Canon Medical Systems
        13.2.1 Canon Medical Systems Company Information
        13.2.2 Canon Medical Systems In Vivo Imaging Systems Product Portfolios and Specifications
        13.2.3 Canon Medical Systems In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Canon Medical Systems Main Business Overview
        13.2.5 Canon Medical Systems Latest Developments
    13.3 Bruker
        13.3.1 Bruker Company Information
        13.3.2 Bruker In Vivo Imaging Systems Product Portfolios and Specifications
        13.3.3 Bruker In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Bruker Main Business Overview
        13.3.5 Bruker Latest Developments
    13.4 Idexx Laboratories
        13.4.1 Idexx Laboratories Company Information
        13.4.2 Idexx Laboratories In Vivo Imaging Systems Product Portfolios and Specifications
        13.4.3 Idexx Laboratories In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Idexx Laboratories Main Business Overview
        13.4.5 Idexx Laboratories Latest Developments
    13.5 Hallmarq Veterinary Imaging
        13.5.1 Hallmarq Veterinary Imaging Company Information
        13.5.2 Hallmarq Veterinary Imaging In Vivo Imaging Systems Product Portfolios and Specifications
        13.5.3 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Hallmarq Veterinary Imaging Main Business Overview
        13.5.5 Hallmarq Veterinary Imaging Latest Developments
    13.6 Huantong Nuclear Magnet
        13.6.1 Huantong Nuclear Magnet Company Information
        13.6.2 Huantong Nuclear Magnet In Vivo Imaging Systems Product Portfolios and Specifications
        13.6.3 Huantong Nuclear Magnet In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Huantong Nuclear Magnet Main Business Overview
        13.6.5 Huantong Nuclear Magnet Latest Developments
    13.7 Sunny Optical
        13.7.1 Sunny Optical Company Information
        13.7.2 Sunny Optical In Vivo Imaging Systems Product Portfolios and Specifications
        13.7.3 Sunny Optical In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Sunny Optical Main Business Overview
        13.7.5 Sunny Optical Latest Developments
    13.8 Photon
        13.8.1 Photon Company Information
        13.8.2 Photon In Vivo Imaging Systems Product Portfolios and Specifications
        13.8.3 Photon In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Photon Main Business Overview
        13.8.5 Photon Latest Developments
    13.9 MILABS
        13.9.1 MILABS Company Information
        13.9.2 MILABS In Vivo Imaging Systems Product Portfolios and Specifications
        13.9.3 MILABS In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 MILABS Main Business Overview
        13.9.5 MILABS Latest Developments
    13.10 iThera Medical
        13.10.1 iThera Medical Company Information
        13.10.2 iThera Medical In Vivo Imaging Systems Product Portfolios and Specifications
        13.10.3 iThera Medical In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 iThera Medical Main Business Overview
        13.10.5 iThera Medical Latest Developments
    13.11 Vieworks
        13.11.1 Vieworks Company Information
        13.11.2 Vieworks In Vivo Imaging Systems Product Portfolios and Specifications
        13.11.3 Vieworks In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Vieworks Main Business Overview
        13.11.5 Vieworks Latest Developments
    13.12 Aspect Imaging
        13.12.1 Aspect Imaging Company Information
        13.12.2 Aspect Imaging In Vivo Imaging Systems Product Portfolios and Specifications
        13.12.3 Aspect Imaging In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Aspect Imaging Main Business Overview
        13.12.5 Aspect Imaging Latest Developments
    13.13 TOMOWAVE
        13.13.1 TOMOWAVE Company Information
        13.13.2 TOMOWAVE In Vivo Imaging Systems Product Portfolios and Specifications
        13.13.3 TOMOWAVE In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 TOMOWAVE Main Business Overview
        13.13.5 TOMOWAVE Latest Developments
    13.14 Trifoil Imaging
        13.14.1 Trifoil Imaging Company Information
        13.14.2 Trifoil Imaging In Vivo Imaging Systems Product Portfolios and Specifications
        13.14.3 Trifoil Imaging In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 Trifoil Imaging Main Business Overview
        13.14.5 Trifoil Imaging Latest Developments
    13.15 Clinx
        13.15.1 Clinx Company Information
        13.15.2 Clinx In Vivo Imaging Systems Product Portfolios and Specifications
        13.15.3 Clinx In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 Clinx Main Business Overview
        13.15.5 Clinx Latest Developments
    13.16 Raylight
        13.16.1 Raylight Company Information
        13.16.2 Raylight In Vivo Imaging Systems Product Portfolios and Specifications
        13.16.3 Raylight In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 Raylight Main Business Overview
        13.16.5 Raylight Latest Developments
    13.17 Spectral Instruments Imaging
        13.17.1 Spectral Instruments Imaging Company Information
        13.17.2 Spectral Instruments Imaging In Vivo Imaging Systems Product Portfolios and Specifications
        13.17.3 Spectral Instruments Imaging In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 Spectral Instruments Imaging Main Business Overview
        13.17.5 Spectral Instruments Imaging Latest Developments
    13.18 Novel Medical
        13.18.1 Novel Medical Company Information
        13.18.2 Novel Medical In Vivo Imaging Systems Product Portfolios and Specifications
        13.18.3 Novel Medical In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.18.4 Novel Medical Main Business Overview
        13.18.5 Novel Medical Latest Developments
    13.19 Tanon
        13.19.1 Tanon Company Information
        13.19.2 Tanon In Vivo Imaging Systems Product Portfolios and Specifications
        13.19.3 Tanon In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.19.4 Tanon Main Business Overview
        13.19.5 Tanon Latest Developments
    13.20 Biolight
        13.20.1 Biolight Company Information
        13.20.2 Biolight In Vivo Imaging Systems Product Portfolios and Specifications
        13.20.3 Biolight In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.20.4 Biolight Main Business Overview
        13.20.5 Biolight Latest Developments
    13.21 PINGSENG Healthcare
        13.21.1 PINGSENG Healthcare Company Information
        13.21.2 PINGSENG Healthcare In Vivo Imaging Systems Product Portfolios and Specifications
        13.21.3 PINGSENG Healthcare In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.21.4 PINGSENG Healthcare Main Business Overview
        13.21.5 PINGSENG Healthcare Latest Developments
    13.22 Fujifilm Visualsonics
        13.22.1 Fujifilm Visualsonics Company Information
        13.22.2 Fujifilm Visualsonics In Vivo Imaging Systems Product Portfolios and Specifications
        13.22.3 Fujifilm Visualsonics In Vivo Imaging Systems Sales, Revenue, Price and Gross Margin (2020-2025)
        13.22.4 Fujifilm Visualsonics Main Business Overview
        13.22.5 Fujifilm Visualsonics Latest Developments

14 Research Findings and Conclusion